Niagen Bioscience

Home
United States
Los Angeles, CA
Niagen Bioscience

There’s a better way to age. Uncovering the potential of NAD+ with precision science.

10/21/2025

Niagen Bioscience (NASDAQ: NAGE), the global authority on NAD+ science and healthy-aging research, announces its Q3 2025 earnings call scheduled for Tuesday, November 4 at 4:30 PM ET.

Join management for financial results and strategic updates from the leader in NAD+ innovation.

▸ Conference call dial-in: +1 888 596 4144
▸ Conference ID: 8584242

The earnings call will be broadcast live and available for replay via the investor relations section on niagenbioscience.com.

10/20/2025

Want to know what's next in longevity and cellular health?

We're bringing the conversation to in Las Vegas, Oct 19-22 at the Venetian Expo—where 12,000+ healthcare innovators gather to consider the industry's biggest challenges.

📍 October 20, 10:20am PT - Dr. Andrew Shao on the longevity panel, diving into the science of NAD+ optimization.

📍 Speaker Lounge - Niagen Plus IVs on-site for speakers and attendees ready to experience next-level cellular support.

09/30/2025

We’re celebrating International Podcast Day by highlighting our recent appearances across leading podcast platforms. Here are some of our favorite moments where we’ve shared the science behind NAD+ research and cellular health innovation.

From mitochondrial health to supplement safety standards, we’re proud to contribute to important conversations about the future of longevity science.

09/25/2025

Our latest analytical report, featured in , examined 21 top-selling NAD+ supplements and found significant gaps between what's promised and what's delivered.⁠
⁠
The findings? Many liposomal NAD+ products showed major discrepancies between label claims and actual content—highlighting serious quality control issues across the industry.⁠
⁠
Why this matters: While liposome technology has real scientific merit, its misuse creates consumer confusion and erodes trust in legitimate NAD+ supplementation.⁠
⁠
At Niagen Bioscience, we take a different approach. Our Nicotinamide Riboside Chloride is:⁠
✓ Rigorously tested 13 times over for purity and potency⁠
✓ Transparently formulated and third-party verified ⁠
✓ Backed by robust scientific validation⁠
✓ Clinically studied and patented⁠
⁠
The NAD+ space needs more transparency, not more marketing claims. We're committed to advancing the field through scientific integrity—because your cellular health deserves nothing less.⁠
⁠
Read the full feature at the link in our bio.

09/23/2025

What does authenticity mean to CEO Rob Fried? It’s everything. While other brands are busy performing authenticity, we’re busy obsessing over the science.

It’s why you’ll never hear us say Niagen gives you energy—we say it gives you *cellular* energy. Because until a published, peer-reviewed, human study confirms it, we won’t say it.

Other NAD+ supplements may be comfortable making unsubstantiated claims, but for us, authenticity is about walking the walk and talking the talk—and we let the data do the talking.

09/01/2025

We're honored to have Dr. Vilhelm Bohr guiding Niagen® Bioscience's research efforts.

Dr. Bohr is one of the world's most published researchers in aging and neurodegenerative disease, with over 624 journal publications. For three decades, he served as Chief of the Laboratory of Molecular Genetics at the National Institute on Aging (NIH), where he made groundbreaking discoveries about DNA repair pathways, oxidative stress, aging and neurodegeneration

His pioneering work revealed critical connections between DNA damage, mitochondrial dysfunction, and age-related neurodegeneration. Dr. Bohr's research on energy homeostasis has fundamentally shaped our understanding of healthy aging.

Now maintaining his research lab at the University of Copenhagen, Dr. Bohr continues studying the benefits of NR (nicotinamide riboside) – bringing decades of expertise directly to our mission of advancing healthy aging science.

08/29/2025

In a recent interview with NBJ journalist Rick Polito, CEO Rob Fried breaks down how we built the NAD+ category from the ground up—through patient foundation-building, rigorous science, and authentic word-of-mouth. The result? Over $100M in annual sales and 38% growth in Q1 alone.

"The thing about PR and word of mouth is that people think it happens overnight. It doesn't. You build a foundation, and then the fire gets lit." - Rob Fried

Read Rick Polito's full NBJ feature at the link in our bio to learn how NAD went from biohacking early adopter circles to mainstream.

08/27/2025

We're privileged to have Nobel Laureate Dr. Roger Kornberg leading Niagen® Bioscience as Chairman of our Scientific Advisory Board.⁠
⁠
Dr. Kornberg, a Stanford Medical School professor, was awarded the 2006 Nobel Prize in Chemistry for his groundbreaking research on the molecular basis of eukaryotic transcription. His work has fundamentally advanced our understanding of how genetic information is converted into cellular function.⁠
⁠
Since founding his lab at Stanford in 1976, Dr. Kornberg has dedicated his career to reconstituting the entire transcription process using pure proteins and nucleic acids, revealing crucial structural and functional insights.⁠
⁠
Notably, Dr. Kornberg comes from a scientific dynasty—his father, the late Arthur Kornberg, was a 1959 Nobel Prize winner who was among the first researchers to investigate nicotinamide riboside over 60 years ago at NIH, establishing foundational principles of DNA replication and NAD+ synthesis.⁠
⁠
Dr. Kornberg’s research, accomplishments, and remarkable scientific legacy guide our mission today.

08/25/2025

BREAKTHROUGH: Niagen Bioscience, Inc. secures exclusive global rights as a potential Parkinson's treatment.⁠
⁠
This development signals our progression toward approved pharmaceutical applications. Backed by the Phase III NOPARK study, 400 patients across 12 sites in Norway are testing whether our NAD+ precursor can slow disease progression. Results expected by the end of 2025.⁠
⁠
Niagen is proud that its patented form of NR is leading the way in how NAD+ moves from consumer products to life-changing therapies.⁠
⁠
"This milestone underscores our commitment to translating scientific innovation into meaningful therapeutic solutions." - Rob Fried, CEO

08/21/2025

Meet Brunie Felding, Ph.D., Principal Investigator at the Scripps Research Institute, renowned breast cancer researcher, and distinguished member of our Scientific Advisory Board.⁠
⁠
As an Associate Professor in the Department of Translational Medicine at the Scripps Research Institute and Chief Scientific Officer at CureScience Brain Cancer Research Foundation, Dr. Felding is at the forefront of groundbreaking research.⁠
⁠
Her work focuses on breast cancer metastasis and NAD+ metabolism, contributing significantly to our understanding of molecular mechanisms in cancer treatment and prevention. With expertise spanning molecular medicine, genomics, and cancer biology, she brings invaluable insights to the role of NAD+ supplementation in therapeutic interventions.⁠
⁠
We're honored to have Dr. Felding's scientific expertise guiding our mission to advance NAD+ research and bring science-backed solutions to support cellular health.⁠
⁠
Learn more about the science behind Tru Niagen at www.truniagen.com

08/15/2025

Our CEO Rob Fried took the stage at Cannes Lions to share his leadership philosophy—and the took notice.

“The best way to be a trusted brand is to be a trustworthy company," says Rob, who believes in the power of consistent, purpose-driven progress with the precision science to back it up.

Read more for Rob's hot take about "future-proofing" and AI in the full article—link in our bio.

08/12/2025

Meet Dr. Rudolph Tanzi, Harvard neuroscientist, brain health innovator, and member of our Scientific Advisory Board. His extensive research has led to the co-discovery of all three early-onset Alzheimer's disease genes and has earned him recognition as one of TIME's 100 Most Influential People and membership in the National Academy of Medicine.⁠
⁠
Dr. Tanzi’s world-renowned expertise and proven success in translating genetic discoveries into therapeutic solutions bring invaluable insight to Niagen, and we are privileged to count him among our expert advisors.

Address

10900 Wilshire Boulevard Suite 600
Los Angeles, CA
90024

Website

https://linktr.ee/niagenbioscience

Alerts

Be the first to know and let us send you an email when Niagen Bioscience posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Los Angeles?